stars 1 stars 2 stars 3

Enabled by next-gen transdermal delivery technology, MitoSkin formulations work by targeting reactive oxygen species, membrane instability, and mitochondrial dysfunction. These subcellular pathologies reduce the body's ability to recover from disease and environmental stressors contributing to chronic illness and inflammation. Addressing these problems is key for maintaining young and healthy cells. Solutions that don't address these problems are simply covering them up. Enterprise services in: NAD+ Precursor Systemic Delivery Liposomal Delivery Polymer Drug Loading Non-occlusive Transdermal Delivery Mitochondria Density Augmentation Microcavity Encapsulation Raw Material Sourcing and Processing

MitoSkin Questions

MitoSkin is based in Chicago, Illinois.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users